Combination immunotherapy: a road map.
Journal for ImmunoTherapy of Cancer.
Times cited: 1
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. The Lancet Oncology. 2016 Academic Article GET IT
- Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule. Cancers. 2016 Academic Article GET IT
Defining the critical hurdles in cancer immunotherapy.
Journal of translational medicine.
Times cited: 97
- Introduction. 2008 Editorial Article GET IT
Is tumor immunity the same thing as autoimmunity? Implications for cancer immunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 17
- Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
- Clinical applications of p53-directed gene therapy. I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]. 2002 Academic Article GET IT